PharmaEngine Capital Reinvestment Ratio
PharmaEngine capital reinvestment ratio. PharmaEngine (4162) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$53.01 Million) in capital expenditures (NT$115.00K). Check cash flow reinvestment rate of PharmaEngine to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PharmaEngine (2011–2024)
Capital reinvestment ratio of PharmaEngine from 2011 to 2024. This chart tracks PharmaEngine's Capital Reinvestment Ratio across 12 annual periods. Also explore 4162 net asset momentum to track the company's year-over-year net asset growth rate.
PharmaEngine Capital Reinvestment Ratio by Year (2011–2024)
PharmaEngine capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see how efficiently does PharmaEngine generate cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | NT$456.73 Million | NT$1.42 Million | ▼ -16.9% |
| 2023 | 0.00x | NT$256.97 Million | NT$958.00K | ▼ -80.9% |
| 2022 | 0.02x | NT$202.01 Million | NT$3.94 Million | ▲ +7825.9% |
| 2021 | 0.00x | NT$929.67 Million | NT$229.00K | ▼ -97.4% |
| 2020 | 0.01x | NT$64.77 Million | NT$608.00K | ▼ -27.4% |
| 2019 | 0.01x | NT$16.08 Million | NT$208.00K | ▲ +1790.4% |
| 2018 | 0.00x | NT$745.23 Million | NT$510.00K | ▼ -48.0% |
| 2016 | 0.00x | NT$870.38 Million | NT$1.15 Million | ▼ -95.0% |
| 2015 | 0.03x | NT$447.99 Million | NT$11.80 Million | ▲ +3535.1% |
| 2014 | 0.00x | NT$131.09 Million | NT$95.00K | ▼ -40.1% |
| 2012 | 0.00x | NT$68.64 Million | NT$83.00K | ▼ -58.7% |
| 2011 | 0.00x | NT$275.49 Million | NT$806.00K | — |